NASDAQ
Blueprint Medicines Corporation (BPMC) has a current ratio of 2.85x as of Tuesday, May 26, 2026. This represents a 43.79% decrease compared to its 12-month average of 5.07x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.